Zydus Lifesciences (ZYDUSLIFE) — Annual Report

Zydus Lifesciences Limited reported FY 2024-25 revenue of ₹232.4 billion, up 19% YoY, with EBITDA growing 31% to ₹70,585 million and net profit rising 23% to ₹47,451 million. The company strengthened its balance sheet with net cash of ₹48,836 million and a negative net debt ratio, reflecting robust financial health. Strategic investments focused on innovation, including biosimilars, oncology, and medtech, supported by R&D spending of 8% of revenue. Sustainability efforts advanced with 91% renewable energy growth and net carbon neutrality target by 2028. Governance remained strong with board oversight of ESG, risk, and CSR, and no material audit or regulatory issues identified.

📄 View Original Announcement (PDF)

📊 Stock Analysis — ZYDUSLIFE ✨ Ask AI About This

About Zydus Lifesciences Limited (ZYDUSLIFE)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,01,800.69 Cr P/E: 22.5

View full ZYDUSLIFE stock details →

📡 Get AI alerts when ZYDUSLIFE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ZYDUSLIFE — Free

💡 Ask AI about this filing

"How does this annual report affect Zydus Lifesciences Limited's outlook?" "What did Zydus Lifesciences Limited announce on 16 July 2025?" "Is this positive or negative for ZYDUSLIFE?"

Ask AI Free →

📊 More ZYDUSLIFE filings

See all ZYDUSLIFE filings →

🔥 Also filed on 16 July 2025

BHARTIARTL Bharti Airtel Limited Annual Report BHARTIARTL Bharti Airtel Limited Annual Report TECHM Tech Mahindra Limited Financial Results UNIONBANK Union Bank of India Financial Results WIPRO Wipro Limited Corporate Action CONCOR Container Corporation of India Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ZYDUSLIFE files new disclosures

Track ZYDUSLIFE filings, board meetings, and corporate actions. Free email alerts at 5 PM.